Lista de obras - Daria Handkiewicz-Junak - Dominio Público Uruguay

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

artículo científico publicado en 2009

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

artículo científico publicado en 2008

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

artículo científico publicado en 2017

Childhood thyroid carcinoma — single-centre experience

artículo científico publicado en 2021

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

artículo científico publicado en 2018

Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2017

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

artículo científico publicado en 2022

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2017

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2013

Diagnostics and Treatment of Thyroid Carcinoma

artículo científico publicado en 2016

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

artículo científico publicado en 2016

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

artículo científico publicado en 2020

Differentiated thyroid cancer in children and adults: same or distinct disease?

artículo científico publicado en 2007

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.

artículo científico publicado en 2017

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.

artículo científico publicado en 2018

EANM procedure guidelines for therapy of benign thyroid disease

artículo científico publicado en 2010

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

artículo científico publicado en 2020

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

artículo científico publicado en 2019

Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?

scientific article published on 01 May 2020

Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2017

Gene expression profiles for radiation-induced thyroid cancer

scientific article published on 15 March 2011

Gene signature of the post-Chernobyl papillary thyroid cancer

artículo científico publicado en 2016

Genetic predisposition to papillary thyroid cancer

artículo científico publicado en 2010

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

artículo científico publicado en 2018

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

artículo científico publicado en 2022

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

artículo científico publicado en 2005

Laparoscopic cortical sparing adrenal surgery in pheochromocytomas associated with hereditary neoplasia syndromes

artículo científico publicado en 2020

Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.

artículo científico publicado en 2009

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

artículo científico publicado en 2010

Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2017

Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2013

Neuroendocrine tumors of the small intestine and the appendix - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)

artículo científico publicado en 2008

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

artículo científico publicado en 2010

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

artículo científico publicado en 2016

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer

artículo científico publicado en 2021

Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

artículo científico publicado en 2017

Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report.

artículo científico publicado en 2017

Polish Experience in Peptide Receptor Radionuclide Therapy

scientific article published on 01 January 2013

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

scientific article published on 05 September 2019

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

artículo científico publicado en 2010

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

artículo científico publicado en 2004

Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

artículo científico publicado en 2000

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

artículo científico publicado en 2003

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

scientific article published on 30 September 2015

Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.

artículo científico publicado en 2009

Sorafenib for the treatment of thyroid cancer: an updated review.

artículo científico publicado en 2015

Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]

scientific article published on 01 January 2019

Survey on Paediatric Differentiated Thyroid Cancer Care in Europe.

artículo científico publicado en 2017

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

scientific article published on 17 June 2020

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

artículo científico publicado en 2015

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

artículo científico publicado en 2013

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

artículo científico publicado en 2021

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

artículo científico publicado en 2022

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

artículo científico publicado en 2007

[131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study.]

artículo científico publicado en 2018

[Completion total thyroidectomy in children with differentiated thyroid cancer]

artículo científico publicado en 2006

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

artículo científico publicado en 2010

[Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)]

artículo científico publicado en 2008

[Gene expression analysis by DNA microarray in papillary thyroid cancer]

artículo científico publicado en 2005

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

artículo científico publicado en 2006

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

artículo científico publicado en 2006

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]

artículo científico publicado en 2006

[The usefulness of MIBI scintigraphy for postoperative monitoring of patients with thyroid cancer]

artículo científico publicado en 1999

Lista de obras de Daria Handkiewicz-Junak

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

Childhood thyroid carcinoma — single-centre experience

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).

Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).

Diagnostics and Treatment of Thyroid Carcinoma

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

Differentiated thyroid cancer in children and adults: same or distinct disease?

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.

EANM procedure guidelines for therapy of benign thyroid disease

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium.

Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?

Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Gene expression profiles for radiation-induced thyroid cancer

Gene signature of the post-Chernobyl papillary thyroid cancer

Genetic predisposition to papillary thyroid cancer

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review

Laparoscopic cortical sparing adrenal surgery in pheochromocytomas associated with hereditary neoplasia syndromes

Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.

Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions

Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Neuroendocrine neoplasms of the small intestine and the appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Neuroendocrine tumors of the small intestine and the appendix - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)

Occurrence of BRAF mutations in a Polish cohort of PTC patients - preliminary results.

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer

Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).

Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report.

Polish Experience in Peptide Receptor Radionuclide Therapy

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas.

Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.

Sorafenib for the treatment of thyroid cancer: an updated review.

Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]

Survey on Paediatric Differentiated Thyroid Cancer Care in Europe.

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

[131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study.]

[Completion total thyroidectomy in children with differentiated thyroid cancer]

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

[Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)]

[Gene expression analysis by DNA microarray in papillary thyroid cancer]

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]

[The usefulness of MIBI scintigraphy for postoperative monitoring of patients with thyroid cancer]